Lu, J Q <br/><br/>
Somatostatin modulates the behavioral effects of dopamine receptor activation in parkinsonian rats.  [electronic resource] 

 -  Neuroscience  2002 
 - 261-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0306-4522 
<br/><br/><label>Standard No.: </label>10.1016/s0306-4522(02)00081-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apomorphine--pharmacology<br/>Autoradiography<br/>Behavior, Animal--drug effects<br/>Binding, Competitive--drug effects<br/>Corpus Striatum--drug effects<br/>Disease Models, Animal<br/>Dopamine Agonists--pharmacology<br/>Dopamine Plasma Membrane Transport Proteins<br/>Dose-Response Relationship, Drug<br/>Drug Administration Routes<br/>Male<br/>Medial Forebrain Bundle--drug effects<br/>Membrane Glycoproteins<br/>Membrane Transport Proteins--analysis<br/>Nerve Tissue Proteins<br/>Oxidopamine<br/>Parkinsonian Disorders--chemically induced<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Dopamine--drug effects<br/>Somatostatin--administration & dosage